在接受皮肤冠状动脉干预的患者中出现出血并发症
Mattia Galli1,2, Renzo Laborante1, Felicita Andreotti1,3
1Department of Cardiovascular and Pulmonary Sciences, Catholic University of the Sacred Heart, 00168 Rome, Italy.
Reviews in cardiovascular medicine
|July 30, 2024
概括
穿皮冠状动脉干预 (PCI) 会增加出血风险,因此需要采取减轻这种并发症的策略. 研究重点是新设备,技术和药物,以减少PCI患者的出血.
科学领域:
- 心脏病学 心脏病学
- 干预心脏病学 干预心脏病学
背景情况:
- 穿皮冠状动脉干预 (PCI) 是冠状动脉疾病的常见程序.
- 虽然PCI通常是安全的,但与显著的短期和长期出血风险有关.
- 在PCI后的出血并发症与患者不良结果有关.
研究的目的:
- 审查接受PCI的患者出血的机制和患病率.
- 讨论当前的证据和管理出血风险的实际方法.
- 探索未来预防和治疗出血并发症的策略.
主要方法:
- 对PCI患者出血研究的文献综述.
- 分析当前的抗血栓治疗方法及其对出血的影响.
- 讨论旨在减少出血的新型PCI设备和技术.
主要成果:
- 由于必要的抗血栓治疗,PCI患者面临持续出血的风险.
- 流血是这个人群中不良结果的重要预测因素.
- 目前正在进行的研究正在探索各种方法,以尽量减少出血事件.
结论:
- 减少出血是PCI管理的一个关键目标.
- 必须采用多方面的方法,包括优化的抗血栓策略和创新的技术.
- 需要进一步的研究来完善出血预防和治疗方案.
相关概念视频
Disorders of Hemostasis
781
Hemostasis, the process that stops bleeding after a blood vessel injury, is crucial for maintaining the integrity of the circulatory system. However, disorders of hemostasis can disrupt this delicate balance, leading to either excessive clotting or bleeding. These disorders can be broadly classified into thromboembolic disorders and bleeding disorders.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
781
Inflammatory Bowel Disease I: Ulcerative Colitis
160
Introduction
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
160
Anticoagulant Drugs: Low-Molecular-Weight Heparins
659
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
659
Extrinsic and Intrinsic Pathways of Hemostasis
6.8K
Blood clotting or coagulation involves extrinsic and intrinsic pathways, which ultimately merge into the common pathway, forming a fibrin clot.
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
6.8K
Introduction to Hemostasis
6.9K
Hemostasis is a complex physiological process that prevents excessive bleeding when a blood vessel is injured. It's crucial for maintaining the integrity of the circulatory system, as it ensures that our blood remains fluid while still within the vascular network and yet clots to prevent blood loss upon vessel injury.
The three phases of hemostasis involve many clotting factors present in plasma and several substances released by platelets and injured tissue cells. It is a fast, localized,...
The three phases of hemostasis involve many clotting factors present in plasma and several substances released by platelets and injured tissue cells. It is a fast, localized,...
6.9K


